Searched for
MEGA FINE PHARMA
For investor with a 2-3 year perspective: 5 stocks from 3 sectors with an upside potential of up to 39%Consider this. A company has implemented a restructuring plan and the numbers are showing a positive impact. So, should a decline in the st...
Motilal Oswal Alternates invests Rs 460 cr for majority stake in Mega Fine PharmaMotilal Oswal Alternates on Tuesday announced a Rs 460-crore investment in Mega Fine Pharma for a majority stake. The Sanghvi family, the p...
We are bullish on power capex, rural consumption and pharma sector: Manish GunwaniAnd I think a lot of the smaller companies will, if they have a good business model, good management team, if they are on the right side of...
After delivering many multibagger stocks, will this sector continue to impress?JM Financial says Deepak Nitrite is its top bet in the chemicals sector as despite its inherent cost advantages for its upcoming phenol der...
Market trend moving from small is beautiful to big is great: Basant MaheshwariIn midcap IT, you can always find that one isolated bet and make money, says Basant Maheshwari.
Looking for winners? Consider these 4 bank stocks: N Jayakumar, Prime SecuritiesIn select pharma stocks, there could be 30-40% upside in next 12-18 months, says Prime Securities MD.
Stocks in focus: IDBI Bank, Tata Steel, RITES & Fine Organic among top stocks to trackHere is a list of top stocks that are likely to be in focus in today's trading session -
There are 2 mega investment themes for next 5-6 years: Saurabh Mukherjea"Formal financial savings will rise rapidly over the next 10 years," says Mukherjea.
Consumption, auto and metal stocks to lead earnings surprise in next two years: Sandeep Bhatia, Macquarie CapitalI would go in for FY18-FY19 with around 16% to 18% earnings growth but that is something which I would expect to get revised upwards for a ...
Around Rs 5000 Crore investment in pipeline: Assam Industry minister Chandra Mohan PatwaryAssam industry minister, Chandra Mohan Patwary said that government of India is expected to announce new North East Industrial and Investme...
Andrew Witty leaves GSK with new challenges, robust pipelineThe next wave of drug launches from an active pipeline of 25 clinical programmes will determine how strongly GSK charts its future growth.
Fifteen stocks in focus on Monday, 24 October 2016The Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.
Speciality chemicals can be next mega trend; 15 stocks more than doubled investors wealthThe industry accounts for 3% of the global specialty chemicals market. It delivered 13% growth over the past 5 years, primarily led by dome...
21st century regulator CCI should move with times: Ashok ChawlaEmphasising that CCI has worked quite hard to streamline its systems and processes, the chairman said the endeavour is to deliver better.
Sensex slips over 300 points after exit polls predict AAP government in DelhiDisappointing Q3 earnings over the weekend also weighed on sentiment as current stock valuations, had priced in the prospect of higher prof...
Fifteen stocks in focus in Monday morning tradeIndian markets are expected to trade lower. Here is a list of fifteen stocks which are likely to be in focus today.
CCI packs punch for fairness; slaps Rs 2,700 crore fine in 2014Even as a perception persists about the CCI being yet another hurdle for doing business, the regulator cleared nearly 70 merger and acquisi...
See global trade towards equities due to market volatility: Satish RamanathanAs domestic investors are concerned, it is coming in indirectly through the insurance sector, but DIIs and all the other people are facing ...
- It's time to usher in nanomedicine revolution
Like information technology, India could well usher in the nanomedicine revolution. Spearheading this mission are two Indian researchers, K...
- DCGI pill to check patent misuse a case of overdose
A late and originally hesitant endorser, India, in its overzealousness, is planning moves that even Western countries are have refused to a...